IART Q2 2020 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$259M-32.6% YoY

Gross Profit

$153M59.2% margin

Operating Income

$14M5.4% margin

Net Income

-$369,000-0.1% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-27.0%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$26M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$2.0B

Stockholders' Equity

$1.3B

Cash & Equivalents

$361M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$259M	$384M	-32.6%
Gross Profit	$153M	$240M	-36.2%
Operating Income	$14M	$46M	-69.4%
Net Income	-$369,000	$30M	-101.2%

Revenue Segments

Codman Specialty Surgical

$170M66%

Orthopedics and Tissue Technologies

$89M34%

Geographic Segments

UNITED STATES

$182M70%

Asia Pacific

$34M13%

Europe

$32M12%

Rest Of World

$11M4%